RS50933B - Izoindolin-1-on aktivatori glukokinaze - Google Patents
Izoindolin-1-on aktivatori glukokinazeInfo
- Publication number
- RS50933B RS50933B YUP-477/03A YUP47703A RS50933B RS 50933 B RS50933 B RS 50933B YU P47703 A YUP47703 A YU P47703A RS 50933 B RS50933 B RS 50933B
- Authority
- RS
- Serbia
- Prior art keywords
- ring
- alkyl
- membered
- monosubstituted
- carbon atoms
- Prior art date
Links
- 102000030595 Glucokinase Human genes 0.000 title 1
- 108010021582 Glucokinase Proteins 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- PXZQEOJJUGGUIB-UHFFFAOYSA-N isoindolin-1-one Chemical compound C1=CC=C2C(=O)NCC2=C1 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 4
- 150000001721 carbon Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Jedinjenje formule:naznačeno time stoA predstavlja nesupstituisani fenil ili fenil koji može biti mono- ili disupstituisan halogenom ili monosupstituisan C1-C10-alkil sulfonil, C1-C10-alkil tio ili nitro grupom;R1 predstavlja cikloalkil sa 3 do 9 atoma ugljenika ili alkil sa 2 do 4 atoma ugljenika;R2 predstavlja neki nesupstituisani ili monpsupstituisani petočlani ili šestočlani heteroaromatični prsten, koji je preko atoma ugljenika iz prstena povezan sa prikazanom amino grupom, pri čemu petočlani ili šestočlani heteroaromatični prsten sadrži 1 do 3 heteroatoma izabrana između sumpora, kiseonika ili azota, od kojih je jedan od heteroatoma azot koji je pored vezujućeg atoma ugljenika iz prstena, pri čemu je prsten monocikličan ili fuzionisan sa fenilom preko dva od svojih atoma ugljenika iz prstena, pri čemu je pomenuti monosupstituisani heteroaromatični prsten monosupstituisan na poziciji ugljenika iz prstena različitoj od one pored vezujućeg atoma ugljenika, i to supstituentom izabranim iz grupe koja se sastoji od halogena, C1-C10-alkil, nitro, cijano, perfluoro-C1-C10-alkil; hidroksi, -(CH2)n-OR3, -(CH2)n-C(O)-OR3, -(CH2)n-C(O)-NH-R3, -C(O)C(O)-OR3 ili (CH2)n-NHR3; R3 je vodonik ili C1-C10-alkil; a n je 0, 1,2,3 ili 4;ili njegove farmaceutski prihvatljive soli ili N-oksidi.Prijava sadrži još 19 patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25527300P | 2000-12-13 | 2000-12-13 | |
US31871501P | 2001-09-13 | 2001-09-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU47703A YU47703A (sh) | 2006-05-25 |
RS50933B true RS50933B (sr) | 2010-08-31 |
Family
ID=26944583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-477/03A RS50933B (sr) | 2000-12-13 | 2001-12-07 | Izoindolin-1-on aktivatori glukokinaze |
Country Status (36)
Country | Link |
---|---|
US (1) | US6482951B2 (sr) |
EP (1) | EP1349856B1 (sr) |
JP (1) | JP4021766B2 (sr) |
KR (1) | KR100520651B1 (sr) |
CN (1) | CN1247574C (sr) |
AT (1) | ATE297922T1 (sr) |
AU (2) | AU3841502A (sr) |
BG (1) | BG107903A (sr) |
BR (1) | BR0116169A (sr) |
CA (1) | CA2430579C (sr) |
CY (1) | CY1105587T1 (sr) |
CZ (1) | CZ20031882A3 (sr) |
DE (1) | DE60111570T2 (sr) |
DK (1) | DK1349856T3 (sr) |
EG (1) | EG24358A (sr) |
ES (1) | ES2243578T3 (sr) |
HK (1) | HK1063314A1 (sr) |
HR (1) | HRP20030450B1 (sr) |
HU (1) | HUP0400587A3 (sr) |
IL (2) | IL156264A0 (sr) |
MA (1) | MA26973A1 (sr) |
MX (1) | MXPA03005170A (sr) |
MY (1) | MY136741A (sr) |
NO (1) | NO325810B1 (sr) |
NZ (1) | NZ526236A (sr) |
PA (1) | PA8534601A1 (sr) |
PE (1) | PE20020593A1 (sr) |
PL (1) | PL366006A1 (sr) |
PT (1) | PT1349856E (sr) |
RS (1) | RS50933B (sr) |
RU (1) | RU2249590C2 (sr) |
SI (1) | SI1349856T1 (sr) |
SK (1) | SK8732003A3 (sr) |
TW (1) | TWI294876B (sr) |
UY (1) | UY27069A1 (sr) |
WO (1) | WO2002048106A2 (sr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
DE60316709T2 (de) | 2002-10-03 | 2008-07-17 | F. Hoffmann-La Roche Ag | Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren |
AU2003302279B2 (en) | 2002-10-03 | 2008-06-12 | Novartis Ag | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of Type 2 diabetes |
GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
WO2004063194A1 (en) * | 2003-01-06 | 2004-07-29 | Eli Lilly And Company | Heteroaryl compounds |
WO2004072066A1 (en) * | 2003-02-11 | 2004-08-26 | Prosidion Limited | Tri(cyclo) substituted amide glucokinase activator compounds |
PL378117A1 (pl) * | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
US7320992B2 (en) * | 2003-08-25 | 2008-01-22 | Amgen Inc. | Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use |
CN1960995B (zh) | 2004-04-02 | 2010-12-08 | 诺瓦提斯公司 | 作为葡糖激酶活化剂、可用于治疗ⅱ型糖尿病的磺酰胺-噻唑并吡啶衍生物 |
RU2006138426A (ru) * | 2004-04-02 | 2008-05-10 | Новартис АГ (CH) | Производные тиазолопиридина, содержащие их фармацевтические композиции и способы лечения состояний, опосредованных глюкокиназой |
CA2621227A1 (en) * | 2005-08-31 | 2007-03-08 | Astellas Pharma Inc. | Thiazole derivative |
JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
GT200600429A (es) * | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
GT200600428A (es) * | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
JP2009513711A (ja) * | 2005-11-01 | 2009-04-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | グルコキナーゼのアロステリックモジュレーターとしての置換ピロロン |
JP2009513704A (ja) * | 2005-11-01 | 2009-04-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | グルコキナーゼのアロステリックモジュレーターとしての置換ジヒドロイソインドロン |
CN101321747A (zh) * | 2005-11-01 | 2008-12-10 | 詹森药业有限公司 | 作为葡萄糖激酶变构调节剂的取代的环烷基吡咯酮类 |
EP1951706A1 (en) | 2005-11-01 | 2008-08-06 | Janssen Pharmaceutica N.V. | Dihydroisoindolones as allosteric modulators of glucokinase |
JP2009514835A (ja) * | 2005-11-03 | 2009-04-09 | プロシディオン・リミテッド | トリシクロ置換型アミド |
JP2009515997A (ja) * | 2005-11-18 | 2009-04-16 | タケダ サン ディエゴ インコーポレイテッド | グルコキナーゼ活性剤 |
WO2007104034A2 (en) * | 2006-03-08 | 2007-09-13 | Takeda San Diego, Inc. | Glucokinase activators |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
ATE522518T1 (de) * | 2006-05-31 | 2011-09-15 | Takeda San Diego Inc | Indazol- und isoindolderivate als glucokinaseaktivierende stoffe |
WO2008074694A1 (en) * | 2006-12-20 | 2008-06-26 | F. Hoffmann-La Roche Ag | Crystallization of glucokinase activators |
EP2091947A2 (en) * | 2006-12-20 | 2009-08-26 | Takeda San Diego, Inc. | Glucokinase activators |
TW200831081A (en) * | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
US8034819B2 (en) | 2007-03-07 | 2011-10-11 | Kyorin Pharmaceutical Co., Ltd. | Glucokinase activator |
US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
PE20091313A1 (es) * | 2008-01-15 | 2009-09-03 | Lilly Co Eli | (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina |
WO2009092432A1 (en) * | 2008-01-24 | 2009-07-30 | Merck Patent Gmbh | Beta-amino acid derivatives for treatment of diabetes |
PL2275414T3 (pl) | 2008-04-28 | 2016-01-29 | Kyorin Seiyaku Kk | Pochodne cyklopentyloakryloamidu |
WO2009140624A2 (en) | 2008-05-16 | 2009-11-19 | Takeda San Diego, Inc. | Glucokinase activators |
CN102216276A (zh) * | 2008-09-11 | 2011-10-12 | 辉瑞大药厂 | 取代的杂芳基物 |
CN105176930B (zh) | 2010-03-31 | 2021-05-04 | 斯克里普斯研究所 | 重编程细胞 |
US8178689B2 (en) * | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
JP6251038B2 (ja) | 2011-03-01 | 2017-12-20 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcアゴニストの調製方法 |
US8470866B2 (en) * | 2011-05-03 | 2013-06-25 | Hoffmann-La Roche Inc. | Isoindolinone derivatives |
RS59663B1 (sr) * | 2013-05-27 | 2020-01-31 | Hoffmann La Roche | Nova jedinjenja 3,4-dihidro-2h-izokinolin-1-on i 2,3-dihidro-izoindol-1-on |
US10011637B2 (en) | 2013-06-05 | 2018-07-03 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
MX2017002610A (es) | 2014-08-29 | 2017-10-11 | Tes Pharma S R L | INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA. |
US20180134667A1 (en) | 2016-10-14 | 2018-05-17 | TES Pharma S.r.I. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
MX2021005904A (es) | 2018-11-20 | 2021-09-08 | Tes Pharma S R L | Inhibidores de la ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687147A1 (fr) * | 1992-02-11 | 1993-08-13 | Union Pharma Scient Appl | Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant. |
SI1169312T1 (en) | 1999-03-29 | 2005-02-28 | F. Hoffmann-La Roche Ag | Glucokinase activators |
DK1280801T3 (da) | 2000-05-03 | 2006-01-23 | Hoffmann La Roche | Hydantoinholdige glucokinaseaktivatorer |
MXPA02010796A (es) | 2000-05-08 | 2003-03-27 | Hoffmann La Roche | Fenilacetamidas sustituidas y sus usos como activadores de glucocinasa. |
-
2001
- 2001-12-06 US US10/010,978 patent/US6482951B2/en not_active Expired - Fee Related
- 2001-12-07 CA CA2430579A patent/CA2430579C/en not_active Expired - Fee Related
- 2001-12-07 KR KR10-2003-7007869A patent/KR100520651B1/ko not_active IP Right Cessation
- 2001-12-07 DE DE60111570T patent/DE60111570T2/de not_active Expired - Lifetime
- 2001-12-07 CN CNB018206107A patent/CN1247574C/zh not_active Expired - Fee Related
- 2001-12-07 SK SK873-2003A patent/SK8732003A3/sk unknown
- 2001-12-07 ES ES01986857T patent/ES2243578T3/es not_active Expired - Lifetime
- 2001-12-07 PL PL01366006A patent/PL366006A1/xx unknown
- 2001-12-07 NZ NZ526236A patent/NZ526236A/xx unknown
- 2001-12-07 WO PCT/EP2001/014404 patent/WO2002048106A2/en active IP Right Grant
- 2001-12-07 SI SI200130381T patent/SI1349856T1/xx unknown
- 2001-12-07 RS YUP-477/03A patent/RS50933B/sr unknown
- 2001-12-07 AT AT01986857T patent/ATE297922T1/de active
- 2001-12-07 JP JP2002549637A patent/JP4021766B2/ja not_active Expired - Fee Related
- 2001-12-07 MX MXPA03005170A patent/MXPA03005170A/es active IP Right Grant
- 2001-12-07 DK DK01986857T patent/DK1349856T3/da active
- 2001-12-07 RU RU2003120512/04A patent/RU2249590C2/ru not_active IP Right Cessation
- 2001-12-07 AU AU3841502A patent/AU3841502A/xx active Pending
- 2001-12-07 IL IL15626401A patent/IL156264A0/xx unknown
- 2001-12-07 CZ CZ20031882A patent/CZ20031882A3/cs unknown
- 2001-12-07 AU AU2002238415A patent/AU2002238415B2/en not_active Ceased
- 2001-12-07 HU HU0400587A patent/HUP0400587A3/hu unknown
- 2001-12-07 PT PT01986857T patent/PT1349856E/pt unknown
- 2001-12-07 BR BR0116169-5A patent/BR0116169A/pt not_active Application Discontinuation
- 2001-12-07 EP EP01986857A patent/EP1349856B1/en not_active Expired - Lifetime
- 2001-12-10 PA PA20018534601A patent/PA8534601A1/es unknown
- 2001-12-10 EG EG20011316A patent/EG24358A/xx active
- 2001-12-10 TW TW090130510A patent/TWI294876B/zh not_active IP Right Cessation
- 2001-12-11 PE PE2001001234A patent/PE20020593A1/es not_active Application Discontinuation
- 2001-12-11 MY MYPI20015613A patent/MY136741A/en unknown
- 2001-12-12 UY UY27069A patent/UY27069A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 IL IL156264A patent/IL156264A/en not_active IP Right Cessation
- 2003-06-04 HR HR20030450A patent/HRP20030450B1/xx not_active IP Right Cessation
- 2003-06-12 NO NO20032674A patent/NO325810B1/no not_active IP Right Cessation
- 2003-06-12 MA MA27197A patent/MA26973A1/fr unknown
- 2003-06-13 BG BG107903A patent/BG107903A/bg unknown
-
2004
- 2004-08-11 HK HK04106031A patent/HK1063314A1/xx not_active IP Right Cessation
-
2005
- 2005-09-15 CY CY20051101133T patent/CY1105587T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS50933B (sr) | Izoindolin-1-on aktivatori glukokinaze | |
EA200100755A1 (ru) | 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты | |
CA2429642A1 (en) | Fused heteroaromatic glucokinase activators | |
ATE340173T1 (de) | Piperazin- und piperidin- derivate | |
DE68905979D1 (de) | Antidepressive n-substitierte nikotinamid-verbindungen. | |
AR035639A1 (es) | Derivados de para-aril o heterociclil sustituidos activadores de fenilglucoquinasa, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la preparacion de medicamentos. | |
DE69942801D1 (de) | Heterozyklische indolderivate und mono- oder diazaindol-derivate | |
HRP20040429B1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
HRP20010200B1 (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors | |
CO5601027A2 (es) | Derivados de imidazol-4-il-etinil-piridina | |
UA19304A (uk) | Фуhгіцидhий засіб | |
BR0209334A (pt) | Aminas n-aroil cìclicas | |
CA2250840A1 (en) | Antivirally active heterocyclic azahexane derivatives | |
EA200400452A1 (ru) | Производные 3-замещенных 4-пиримидонов | |
DK249089D0 (da) | Benzamid-forbindelser, der er nyttige som protease-inhibitorer | |
WO2003031442A1 (fr) | Composes heterocycliques, derives oxazole, procede permettant de les presenter et leur utilisation | |
CA2163028A1 (en) | New thiazolidinediones and pharmaceutical agents containing them | |
WO2000005223A3 (en) | Heterocyclic derivatives and their use as integrin inhibitors | |
NO931366D0 (no) | 1,2,4-oksadiazolylfenoksyalkylisoksazoler og deres anvendelse som antivirale midler | |
UA66756C2 (uk) | Сполуки піперазину та піперидину, спосіб одержання сполук та спосіб лікування розладів центральної нервової системи | |
NO901926D0 (no) | Arylimidazoler med pesticid virkning, deres fremstilling og anvendelse. | |
ES2190252T3 (es) | Derivados de 2-fenilpiran-4-ona. | |
HRP20010630B1 (en) | 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists | |
NO20033131L (no) | Anvendelse av 2-amino-4-pyridylmetyl-tiazolinderivater som inhibitorer forinduktibel NO-syntase | |
PE20060339A1 (es) | Heterociclos monociclicos como inhibidores de cinasa |